Bio-Connect
Immunohistochemical staining of formalin-fixed and paraffin embedded human breast cancer tissue sections using anti-VISTA Rabbit Monoclonal Antibody (RM503) at 1:100 dilution.
Immunohistochemical staining of formalin-fixed and paraffin embedded human breast cancer tissue sections using anti-VISTA Rabbit Monoclonal Antibody (RM503) at 1:100 dilution.
Immunohistochemical staining of formalin-fixed and paraffin embedded human breast cancer tissue sections using anti-VISTA Rabbit Monoclonal Antibody (RM503) at 1:100 dilution.

anti-VISTA, Rabbit Monoclonal (RM503)

Research Use Only
REV-31-1395-00
RevMAb Biosciences
Product group Antibodies
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    RevMAb Biosciences
  • Product Name
    anti-VISTA, Rabbit Monoclonal (RM503)
  • Delivery Days Customer
    10
  • Certification
    Research Use Only
  • Clonality
    Monoclonal
  • Scientific Description
    Human VISTA is a 55 to 65kDa type I Ig membrane protein with the extracellular domain homologous to PD-L1. VISTA is mainly expressed on hematopoietic tissues (spleen, thymus and bone marrow) and on myeloid cells with lower expression on CD4+ and CD8+ T cells. VISTA is a new negative checkpoint regulator that potently suppresses T cell activation. Overexpression of VISTA on tumors inhibits the protective anti-tumor immunity and blockade of VISTA enhances antitumor immunity in multiple tumor models. VISTA on APC delivers negative signaling to T cells via a yet-to-identify binding partner on T cells. - Recombinant Antibody. This antibody reacts to human, mouse or rat VISTA. Isotype: Rabbit IgG. Immunogen: A peptide corresponding to residues near the C-terminus of human VISTA. Application: IHC, WB. Liquid. 50% Glycerol/PBS with 1% BSA and 0.09% sodium azide. Human VISTA is a 55 to 65kDa type I Ig membrane protein with the extracellular domain homologous to PD-L1. VISTA is mainly expressed on hematopoietic tissues (spleen, thymus and bone marrow) and on myeloid cells with lower expression on CD4+ and CD8+ T cells. VISTA is a new negative checkpoint regulator that potently suppresses T cell activation. Overexpression of VISTA on tumors inhibits the protective anti-tumor immunity and blockade of VISTA enhances antitumor immunity in multiple tumor models. VISTA on APC delivers negative signaling to T cells via a yet-to-identify binding partner on T cells.
  • Storage Instruction
    -20°C,2°C to 8°C
  • UNSPSC
    12352203